Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020

(2020) Danuta M Skowronski et al.   Eurosurveillance

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018

(2019) Patricia A. Jorquera et al.   Scientific Reports

Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine

(2018) Rebecca Garten et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

(2017) Seth J. Zost et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immune history and influenza virus susceptibility

(2017) Sarah Cobey et al.   Current Opinion in Virology

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

(2017) Nicholas C. Wu et al.   PLoS Pathogens

Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season

(2015) Benjamin S. Chambers et al.   Cell Reports